Grivas, P ;
Plimack, ER ;
Balar, AV...
Grivas , P , Plimack , ER , Balar , AV , Castellano , D , O'Donnell , PH , Bellmunt , J , Powles , T , Hahn , NM , de Wit , R , Bajorin , DF , Ellison , MC , Frenkl , TL , Godwin , JL & Vuky , J 2020 , ' Pembrolizumab as First-line Therapy in Cisplatin-ineligible Advanced Urothelial Cancer (KEYNOTE-052): Outcomes in Older Patients by Age and Performance Status ' , European urology oncology , vol. 3 , no. 3 , pp. 351-359 . https://doi.org/10.1016/j.euo.2020.02.009.
,
2020
